Results

Longboard Pharmaceuticals Inc.

08/09/2024 | Press release | Distributed by Public on 08/09/2024 15:30

Longboard Pharmaceuticals Announces Positive Interim Analysis Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.